CyberArk Named a Leader in 2023 Gartner Magic Quadrant for Privileged Access Management
11.9.2023 18:06:00 EEST | Business Wire | Press release
CyberArk (NASDAQ: CYBR), the identity security company, today announced it has been named a Leader in the 2023 Gartner® Magic Quadrant™ for Privileged Access Management.1 CyberArk is recognized in this report for the fifth consecutive time. Additionally, CyberArk is the only vendor positioned as a Leader in both Gartner Magic Quadrant Privileged Access Management (PAM) and Access Management 2 reports.
The CyberArk Identity Security Platform enables organizations to secure all identities – including workforce, IT, developer and non-human – against cyber threats with intelligent privilege controls. With CyberArk, customers have a single, unified platform for identity security that delivers operational efficiencies and faster ROI. Core to the platform are PAM solutions that secure standing, just-in-time and zero standing privileged access across hybrid and multi-cloud environments, and that improve secrets management to significantly reduce the #1 source of cyber risk: credential theft.
“We are extremely proud to be named a Leader by Gartner again. We believe this recognition underscores our commitment and track record of delivering continuous innovation to meet the evolving needs of our customers,” said Matt Cohen, CEO, CyberArk. “In today’s business and threat environment, every identity is a target for attackers. This is why we continue to extend intelligent privilege controls to all identities – human and machine – while developing deep product integrations across our platform, giving security teams the operational control and visibility they need to secure identities across the enterprise.”
CyberArk believes its consistent recognition as a Leader is the result of its focus on core foundational elements, including:
- Continuous Innovation: CyberArk continues to build upon core strengths in PAM and innovation across its PAM as-a-Service and self-hosted offerings. CyberArk has extended intelligent privilege controls across the entire identity lifecycle, for all types of identities. Recent innovations address emerging use cases for secure, developer-friendly access to public cloud workloads and services. New capabilities include just-in-time privileged access management and low-code and no-code automation workflows that enable automated identity orchestration. CyberArk Secrets Management, an essential part of PAM, is differentiated in its ability to allow organizations to centrally secure, manage and rotate secrets used by the broadest range of application identities. Earlier this year, CyberArk announced expanded secrets management capabilities, new AI-powered policy creation automation for improved endpoint privilege security and the ability for PAM administrators to broker, record and protect native privileged sessions in one-click.
- Exceptional Customer Experience: Globally, CyberArk provides flexible, closely aligned sales, technical and deployment resources to help customers accelerate time to value. Over the past year, CyberArk introduced new training programs and updates to the CyberArk Blueprint for Identity Security Success, in addition to ongoing complimentary access to resources such as the CyberArk Technical Community and CyberArk Success Blog. According to Gartner Peer Insights™, CyberArk has a 91% “would recommend” rating.3
- High Performance and Delivery: CyberArk Security Services, together with its global partner network of channel, MSPs, global systems integrators and advisory firms, help many of the world’s largest enterprises design, deploy and optimize PAM and identity security programs. CyberArk continues to nurture strong and consistent growth among its partner community through expanded training and enablement programs. Now, more than ever, CyberArk’s global ecosystem of C3 Alliance technology partners is critical to helping security teams consolidate and maximize existing investments to mitigate emerging risks and address evolving identity security challenges.
To download a complimentary copy of the 2023 Gartner Magic Quadrant for Privileged Access Management visit: https://www.cyberark.com/gartner-2023-mq-pam
1 – Gartner® Magic Quadrant™ for Privileged Access Management, by Felix Gaehtgens, James Hoover, Michael Kelley, Brian Guthrie, Abhyuday Data, 5 September 2023
2 – Gartner® Magic Quadrant for Access Management, by Henrique Teixeira, Abhyuday Data, Michael Kelley, James Hoover, Brian Guthrie, 1 November 2022
3 – Gartner Peer Insights™ (rating as of Aug. 30, 2023; based on past 12 months), https://www.gartner.com/reviews/market/privileged-access-management/vendor/cyberark
Gartner Disclaimers
GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant and Peer Insights are a registered trademark, of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
About CyberArk
CyberArk (NASDAQ: CYBR) is the global leader in identity security. Centered on intelligent privilege controls, CyberArk provides the most comprehensive security offering for any identity – human or machine – across business applications, distributed workforces, hybrid cloud environments and throughout the DevOps lifecycle. The world’s leading organizations trust CyberArk to help secure their most critical assets. To learn more about CyberArk, visit https://www.cyberark.com, read the CyberArk blogs or follow on LinkedIn, Twitter, Facebook or YouTube.
Copyright © 2023 CyberArk Software. All Rights Reserved. All other brand names, product names, or trademarks belong to their respective holders.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230911021116/en/
Contact information
Media Contacts:
Carissa Ryan, CyberArk
Email: press@cyberark.com
Highwire PR
Email: cyberark@highwirepr.com
Investor Relations:
Erica Smith, CyberArk
Email: ir@cyberark.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
